(US9913810) A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid.
(US9913810) That which is claimed is: 1. A dietary supplement composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain, the composition comprising astaxanthin derived from Haematococcus pluvialis, pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments free from amino acid conjugation and having a molecular weight of 0.5 to 300 kilodaltons (kDa), and a krill or algae oil or phospholipid, wherein the astaxanthin is 0.1 to 15 percent by weight of the krill or algae oil or phospholipid, wherein the composition includes 50 to 500 mg of the krill or algae oil or phospholipid; 0.5 to 12 mg of the astaxanthin derived from Haematococcus pluvialis; and 10 to 70 mg of the pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kDa, and wherein the composition is formulated in an oral dosage form and in a single dosage capsule. 2. The dietary supplement composition according to claim 1, further comprising a pharmaceutical or food grade diluent. 3. The dietary supplement composition according to claim 1, wherein the phospholipid is selected from the group consisting of Phosphatidylcholine, Phosphatidylethanolamine, Phosphatidylserine, Phosphatidylinositol, Phosphatidic acid, Lyso-Phosphatidylcholine, Lyso-Phosphatidylethanolamine, and Lyso-Phosphatidylserine. 4. The dietary supplement composition according to claim 1, wherein the phospholipid comprises at least one of a plant, algae, animal source and synthetic derivative.
(US9913810) LEGAL DETAILS FOR US2015182552 Actual or expected expiration date=2035-03-12 Legal state=ALIVE Status=GRANTED Event publication date=2015-03-12 Event code=US/APP Event indicator=Pos Event type=Examination events Application details Application country=US US14645890 Application date=2015-03-12 Standardized application number=2015US-14645890 Event publication date=2015-03-12 Event code=US/EXMR Event type=Administrative notifications USPTO Examiner Name Primary Examiner: BOWERS, ERIN M Event publication date=2015-03-12 Event code=US/ART Event type=Administrative notifications USPTO Art Group ART=1653 Event publication date=2015-03-12 Event code=US/ENT Event type=Administrative notifications Entity Status Set to Undiscounted Business Entity Status: UNDISCOUNTED Event publication date=2015-03-12 Event code=US/AIA Event type=Administrative notifications First Inventor File Indicated: AIA=Yes Event publication date=2015-03-12 Event code=US/DK Event type=Examination events Attorney Docket Number Docket Nbr: 65452CON1-CIP1 Event publication date=2015-03-12 Event code=US/CUST Event type=Examination events Attorney/Agent Customer Number Customer Nbr: 27975 Event publication date=2015-03-12 Event code=US/PTARDY Event indicator=Pos Event type=Examination events Patent Term Adjustment - Ready for Examination Event publication date=2015-03-12 Event code=US/ENT Event type=Administrative notifications Entity Status Set to Undiscounted Event publication date=2015-03-19 Event code=US/DISCSEF Event type=OAI Electronic Information Disclosure Statement Event publication date=2015-03-19 Event code=US/IDS Event type=Examination events Event type=OAI Information Disclosure Statement Filed Event publication date=2015-03-20 Event code=US/DISCSEF Event type=OAI Electronic Information Disclosure Statement Event publication date=2015-03-25 Event code=US/APPFILEREC Event type=Administrative notifications Event type=OAO Filing Receipt Event publication date=2015-04-21 Event code=US/AS Event type=Change of name or address Event type=Reassignment Assignment Owner: U.S. NUTRACEUTICALS, LLC, D/B/A VALENSA INTERNATIO Effective date of the event=2015-04-07 ASSIGNMENT OF ASSIGNORS INTEREST ASSIGNORS:MINATELLI, JOHN A. HILL, W. STEPHEN MOERCK, RUDI E. REEL/FRAME:035454/0045 Event publication date=2015-06-04 Event code=US/DISCSEF Event type=OAI Electronic Information Disclosure Statement Event publication date=2015-06-04 Event code=US/IDS Event type=Examination events Event type=OAI Information Disclosure Statement Filed Event publication date=2015-07-02 Event code=US/A1 Event type=Examination events Application published Publication country=US Publication number=US2015182552 Publication stage Code=A1 Publication date=2015-07-02 Standardized publication number=US20150182552 Event publication date=2015-07-02 Event code=US/PGPUBN Event indicator=Pos Event type=Examination events Event type=OAO PG-Pub Issue Notification Event publication date=2015-07-23 Event code=US/DISCSEF Event type=OAI Electronic Information Disclosure Statement Event publication date=2015-10-05 Event code=US/DISCSEF Event type=OAI Electronic Information Disclosure Statement Event publication date=2015-10-05 Event code=US/IDS Event type=Examination events Event type=OAI Information Disclosure Statement Filed Event publication date=2015-10-14 Event code=US/DOCK Event indicator=Pos Event type=Examination events Case Docketed to Examiner Event publication date=2015-11-24 Event code=US/RESTREQ Event type=Examination events Event type=Corrections Event type=OAO Restriction/Election Requirement Event publication date=2016-01-19 Event code=US/APE Event type=Corrections Preliminary amendments Event publication date=2016-01-19 Event code=US/ELC Event type=Examination events Event type=OAI Response to Election / Restriction Filed Event publication date=2016-02-11 Event code=US/IDS Event type=Examination events Event type=OAI Information Disclosure Statement Filed Event publication date=2016-03-17 Event code=US/CTNF Event type=Examination events Event type=OA Event type=OAO Non-Final Rejection Event publication date=2016-06-24 Event code=US/INVSUM Event type=Examination events Event type=OAI Event type=INT Interview Summary- Applicant Initiated Event publication date=2016-08-09 Event code=US/136G Event type=OAO Request for Extension of Time - Granted Event publication date=2016-08-09 Event code=US/CTNFR Event type=Examination events Event type=OAI Response after Non-Final Action Event publication date=2016-08-09 Event code=US/IDS Event type=Examination events Event type=OAI Information Disclosure Statement Filed Event publication date=2016-08-09 Event code=US/DC Event indicator=Neg Event type=Examination events Terminal Disclaimer Filed Event publication date=2016-11-01 Event code=US/CTFR Event type=Examination events Event type=OA Event type=OAO Final Rejection Event publication date=2017-01-11 Event code=US/INVSUM Event type=Examination events Event type=OAI Event type=INT Interview Summary- Applicant Initiated Event publication date=2017-05-17 Event code=US/DISCSEF Event type=OAI Electronic Information Disclosure Statement Event publication date=2017-05-17 Event code=US/RCEX Event type=Examination events Event type=RCE Event type=OAI Request for Continued Examination (RCE) Event publication date=2017-05-17 Event code=US/136G Event type=OAO Request for Extension of Time - Granted Event publication date=2017-05-17 Event code=US/IDS Event type=Examination events Event type=OAI Information Disclosure Statement Filed Event publication date=2017-05-18 Event code=US/DRCECAP Event type=RCE Event type=OAO Disposal for a RCE / CPA / R129 Event publication date=2017-06-01 Event code=US/DISCSEF Event type=OAI Electronic Information Disclosure Statement Event publication date=2018-01-11 Event code=US/EXAC Event type=Examination events Event type=OAO Examiner's Amendment Communication Event publication date=2018-01-19 Event code=US/NOAM Event indicator=Pos Event type=Examination events Event type=OAO Mail Notice of Allowance Event publication date=2018-01-30 Event code=US/APRDY Event indicator=Pos Event type=Examination events Application Is Considered Ready for Issue Event publication date=2018-02-21 Event code=US/PAT Event indicator=Pos Event type=Event indicating In Force Patented Case Event publication date=2018-02-21 Event code=US/ISSM Event indicator=Pos Event type=Examination events Event type=OAO Event type=Restitution or restoration Issue Notification Mailed Event publication date=2018-03-13 Event code=US/B2 Event indicator=Pos Event type=Event indicating In Force Granted patent as second publication Publication country=US Publication number=US9913810 Publication stage Code=B2 Publication date=2018-03-13 Standardized publication number=US9913810
最新评论
暂无评论。